[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100503520":3},{"organization":4,"armGroups":7,"interventions":49,"overallOfficials":55,"centralContacts":72,"locations":82,"responsibleParty":414,"collaborators":55,"id":416,"slug":417,"hasResults":418,"nctId":419,"briefTitle":420,"officialTitle":421,"acronym":55,"eligibilityCriteria":422,"healthyVolunteers":418,"sex":423,"minAge":424,"maxAge":55,"enrollmentInfo":425,"targetDuration":55,"studyType":428,"phases":429,"briefSummary":431,"conditions":432,"keywords":436,"overallStatus":85,"whyStopped":55,"lastUpdateSubmitDate":437,"lastUpdatePostDateStruct":438,"startDateStruct":441,"completionDateStruct":443,"leadSponsor":445,"locationsCount":446},{"fullName":5,"class":6},"Incyte Corporation","INDUSTRY",[8,14,17,22,27,32,37,40,43,46],{"label":9,"type":10,"description":11,"interventionNames":12},"Part 1a - Dose Escalation Monotherapy","EXPERIMENTAL","INCA33890 will be administered at the protocol-defined dose based on cohort assignment.",[13],"Drug: INCA33890",{"label":15,"type":10,"description":11,"interventionNames":16},"Part 1b-Dose Expansion Monotherapy",[13],{"label":18,"type":10,"description":19,"interventionNames":20},"Part 2a - Dose Escalation Combination Therapy - Group 1","INCA33890 will be administered in combination with bevacizumab at the protocol-defined dose based on cohort assignment.",[13,21],"Drug: bevacizumab",{"label":23,"type":10,"description":24,"interventionNames":25},"Part 2a - Dose Escalation Combination Therapy - Group 2","INCA33890 will be administered in combination with bevacizumab and FOLFIRI at the protocol-defined dose based on cohort assignment.",[13,21,26],"Drug: FOLFIRI",{"label":28,"type":10,"description":29,"interventionNames":30},"Part 2a - Dose Escalation Combination Therapy - Group 3","INCA33890 will be administered in combination with bevacizumab and FOLFOX at the protocol-defined dose based on cohort assignment.",[13,21,31],"Drug: FOLFOX",{"label":33,"type":10,"description":34,"interventionNames":35},"Part 2a - Dose Escalation Combination Therapy - Group 4","INCA33890 will be administered in combination with cetuximab at the protocol-defined dose based on cohort assignment.",[13,36],"Drug: Cetuximab",{"label":38,"type":10,"description":19,"interventionNames":39},"Part 2b - Dose Expansion Combination Therapy - Group 1",[13,21],{"label":41,"type":10,"description":24,"interventionNames":42},"Part 2b - Dose Expansion Combination Therapy - Group 2",[13,21,26],{"label":44,"type":10,"description":29,"interventionNames":45},"Part 2b - Dose Expansion Combination Therapy - Group 3",[13,21,31],{"label":47,"type":10,"description":34,"interventionNames":48},"Part 2b - Dose Expansion Combination Therapy - Group 4",[13,36],[50,56,60,64,68],{"type":51,"name":52,"description":53,"armGroupLabels":54,"otherNames":55},"DRUG","INCA33890","INCA33890 will be administered at protocol defined dose.",[9,15,18,23,28,33,38,41,44,47],null,{"type":51,"name":57,"description":58,"armGroupLabels":59,"otherNames":55},"bevacizumab","Bevacizumab will be administered at protocol defined dose.",[18,23,28,38,41,44],{"type":51,"name":61,"description":62,"armGroupLabels":63,"otherNames":55},"FOLFIRI","FOLFIRI will be administered at protocol defined dose.",[23,41],{"type":51,"name":65,"description":66,"armGroupLabels":67,"otherNames":55},"FOLFOX","FOLFOX will be administered at protocol defined dose.",[28,44],{"type":51,"name":69,"description":70,"armGroupLabels":71,"otherNames":55},"Cetuximab","Cetuximab will be administered at protocol defined dose.",[33,47],[73,78],{"name":74,"role":75,"phone":76,"phoneExt":55,"email":77},"Incyte Corporation Call Center (US)","CONTACT","1.855.463.3463","medinfo@incyte.com",{"name":79,"role":75,"phone":80,"phoneExt":55,"email":81},"Incyte Corporation Call Center (ex-US)","+800 00027423","eumedinfo@incyte.com",[83,97,103,113,123,133,143,151,161,171,181,190,201,210,219,228,239,248,259,268,277,288,297,303,314,320,329,335,341,352,361,370,381,390,396,405],{"facility":84,"status":85,"city":86,"state":87,"zip":88,"country":89,"countryCode":90,"cosmosGeoPoint":91,"geoPoint":96,"contacts":55},"The Angeles Clinic and Research Institute","RECRUITING","Los Angeles","California","90025","United States","US",{"type":92,"coordinates":93},"Point",[94,95],-118.24368,34.05223,{"lat":95,"lon":94},{"facility":98,"status":85,"city":86,"state":87,"zip":99,"country":89,"countryCode":90,"cosmosGeoPoint":100,"geoPoint":102,"contacts":55},"Valkyrie Clinical Trials","90067",{"type":92,"coordinates":101},[94,95],{"lat":95,"lon":94},{"facility":104,"status":85,"city":105,"state":106,"zip":107,"country":89,"countryCode":90,"cosmosGeoPoint":108,"geoPoint":112,"contacts":55},"Dana Farber Cancer Institute","Boston","Massachusetts","02215",{"type":92,"coordinates":109},[110,111],-71.05977,42.35843,{"lat":111,"lon":110},{"facility":114,"status":85,"city":115,"state":116,"zip":117,"country":89,"countryCode":90,"cosmosGeoPoint":118,"geoPoint":122,"contacts":55},"Cancer and Hematology Centers of Western Michigan-Start Midwest","Grand Rapids","Michigan","49546",{"type":92,"coordinates":119},[120,121],-85.66809,42.96336,{"lat":121,"lon":120},{"facility":124,"status":85,"city":125,"state":126,"zip":127,"country":89,"countryCode":90,"cosmosGeoPoint":128,"geoPoint":132,"contacts":55},"Hackensack University Medical Center","Hackensack","New Jersey","07601",{"type":92,"coordinates":129},[130,131],-74.04347,40.88593,{"lat":131,"lon":130},{"facility":134,"status":85,"city":135,"state":136,"zip":137,"country":89,"countryCode":90,"cosmosGeoPoint":138,"geoPoint":142,"contacts":55},"Nyu Langone Health - Long Island Hospital","Mineola","New York","11501",{"type":92,"coordinates":139},[140,141],-73.64068,40.74927,{"lat":141,"lon":140},{"facility":144,"status":85,"city":136,"state":136,"zip":145,"country":89,"countryCode":90,"cosmosGeoPoint":146,"geoPoint":150,"contacts":55},"Laura and Isaac Perlmutter Cancer Center","10016",{"type":92,"coordinates":147},[148,149],-74.00597,40.71427,{"lat":149,"lon":148},{"facility":152,"status":85,"city":153,"state":154,"zip":155,"country":89,"countryCode":90,"cosmosGeoPoint":156,"geoPoint":160,"contacts":55},"University of Pennsylvania","Philadelphia","Pennsylvania","19104",{"type":92,"coordinates":157},[158,159],-75.16362,39.95238,{"lat":159,"lon":158},{"facility":162,"status":85,"city":163,"state":164,"zip":165,"country":89,"countryCode":90,"cosmosGeoPoint":166,"geoPoint":170,"contacts":55},"Lifespan Cancer Research Institute","Providence","Rhode Island","02903",{"type":92,"coordinates":167},[168,169],-71.41283,41.82399,{"lat":169,"lon":168},{"facility":172,"status":85,"city":173,"state":174,"zip":175,"country":89,"countryCode":90,"cosmosGeoPoint":176,"geoPoint":180,"contacts":55},"University of Texas Md Anderson Cancer Center","Houston","Texas","77030",{"type":92,"coordinates":177},[178,179],-95.36327,29.76328,{"lat":179,"lon":178},{"facility":182,"status":85,"city":183,"state":174,"zip":184,"country":89,"countryCode":90,"cosmosGeoPoint":185,"geoPoint":189,"contacts":55},"South Texas Accelerated Research Therapeutics","San Antonio","78229",{"type":92,"coordinates":186},[187,188],-98.49363,29.42412,{"lat":188,"lon":187},{"facility":191,"status":85,"city":192,"state":55,"zip":193,"country":194,"countryCode":195,"cosmosGeoPoint":196,"geoPoint":200,"contacts":55},"Rigshospitalet Uni of Hospital of Copenhagen","Copenhagen","02100","Denmark","DK",{"type":92,"coordinates":197},[198,199],12.56553,55.67594,{"lat":199,"lon":198},{"facility":202,"status":85,"city":203,"state":55,"zip":204,"country":194,"countryCode":195,"cosmosGeoPoint":205,"geoPoint":209,"contacts":55},"Herlev Og Gentofte Hospital","Herlev","02730",{"type":92,"coordinates":206},[207,208],12.43998,55.72366,{"lat":208,"lon":207},{"facility":211,"status":85,"city":212,"state":55,"zip":213,"country":194,"countryCode":195,"cosmosGeoPoint":214,"geoPoint":218,"contacts":55},"Odense University Hospital","Odense C","05000",{"type":92,"coordinates":215},[216,217],10.39538,55.40841,{"lat":217,"lon":216},{"facility":220,"status":85,"city":221,"state":55,"zip":222,"country":194,"countryCode":195,"cosmosGeoPoint":223,"geoPoint":227,"contacts":55},"Vejle Hospital","Vejle","07100",{"type":92,"coordinates":224},[225,226],9.5357,55.70927,{"lat":226,"lon":225},{"facility":229,"status":85,"city":230,"state":55,"zip":231,"country":232,"countryCode":233,"cosmosGeoPoint":234,"geoPoint":238,"contacts":55},"Centre Leon Berard","Lyon","69373","France","FR",{"type":92,"coordinates":235},[236,237],4.84789,45.74906,{"lat":237,"lon":236},{"facility":240,"status":85,"city":241,"state":55,"zip":242,"country":232,"countryCode":233,"cosmosGeoPoint":243,"geoPoint":247,"contacts":55},"Institut Gustave Roussy","Villejuif","94805",{"type":92,"coordinates":244},[245,246],2.35992,48.7939,{"lat":246,"lon":245},{"facility":249,"status":85,"city":250,"state":55,"zip":251,"country":252,"countryCode":253,"cosmosGeoPoint":254,"geoPoint":258,"contacts":55},"Fondazione Irccs Istituto Nazionale Dei Tumori","Milan","20133","Italy","IT",{"type":92,"coordinates":255},[256,257],12.59836,42.78235,{"lat":257,"lon":256},{"facility":260,"status":85,"city":261,"state":55,"zip":262,"country":252,"countryCode":253,"cosmosGeoPoint":263,"geoPoint":267,"contacts":55},"Irccs Istituto Clinico Humanitas","Rozzano","20089",{"type":92,"coordinates":264},[265,266],9.1559,45.38193,{"lat":266,"lon":265},{"facility":269,"status":85,"city":270,"state":55,"zip":271,"country":252,"countryCode":253,"cosmosGeoPoint":272,"geoPoint":276,"contacts":55},"Centro Ricerche Cliniche Di Verona","Verona","37134",{"type":92,"coordinates":273},[274,275],10.9938,45.43854,{"lat":275,"lon":274},{"facility":278,"status":85,"city":279,"state":55,"zip":280,"country":281,"countryCode":282,"cosmosGeoPoint":283,"geoPoint":287,"contacts":55},"Kansai Medical University Hospital","Hirakata","573-1191","Japan","JP",{"type":92,"coordinates":284},[285,286],135.64914,34.81352,{"lat":286,"lon":285},{"facility":289,"status":85,"city":290,"state":55,"zip":291,"country":281,"countryCode":282,"cosmosGeoPoint":292,"geoPoint":296,"contacts":55},"National Cancer Center Hospital","Tokyo","104-0045",{"type":92,"coordinates":293},[294,295],139.69171,35.6895,{"lat":295,"lon":294},{"facility":298,"status":85,"city":290,"state":55,"zip":299,"country":281,"countryCode":282,"cosmosGeoPoint":300,"geoPoint":302,"contacts":55},"The Cancer Institute Hospital of Jfcr","135-0063",{"type":92,"coordinates":301},[294,295],{"lat":295,"lon":294},{"facility":304,"status":85,"city":305,"state":55,"zip":306,"country":307,"countryCode":308,"cosmosGeoPoint":309,"geoPoint":313,"contacts":55},"Start Barcelona","Barcelona","08023","Spain","ES",{"type":92,"coordinates":310},[311,312],2.15899,41.38879,{"lat":312,"lon":311},{"facility":315,"status":85,"city":305,"state":55,"zip":316,"country":307,"countryCode":308,"cosmosGeoPoint":317,"geoPoint":319,"contacts":55},"Hospital General Universitario Vall D Hebron","08035",{"type":92,"coordinates":318},[311,312],{"lat":312,"lon":311},{"facility":321,"status":85,"city":322,"state":55,"zip":323,"country":307,"countryCode":308,"cosmosGeoPoint":324,"geoPoint":328,"contacts":55},"Fundacion Jimenez Diaz University Hospital","Madrid","28040",{"type":92,"coordinates":325},[326,327],-3.70256,40.4165,{"lat":327,"lon":326},{"facility":330,"status":85,"city":322,"state":55,"zip":331,"country":307,"countryCode":308,"cosmosGeoPoint":332,"geoPoint":334,"contacts":55},"Hospital Universitario 12 de Octubre","28041",{"type":92,"coordinates":333},[326,327],{"lat":327,"lon":326},{"facility":336,"status":85,"city":322,"state":55,"zip":337,"country":307,"countryCode":308,"cosmosGeoPoint":338,"geoPoint":340,"contacts":55},"Centro Integral Oncologico Clara Campal","28050",{"type":92,"coordinates":339},[326,327],{"lat":327,"lon":326},{"facility":342,"status":85,"city":343,"state":55,"zip":344,"country":345,"countryCode":346,"cosmosGeoPoint":347,"geoPoint":351,"contacts":55},"Istituto Oncologico Della Svizzera Italiana","Bellinzona","06500","Switzerland","CH",{"type":92,"coordinates":348},[349,350],9.01703,46.19278,{"lat":350,"lon":349},{"facility":353,"status":85,"city":354,"state":55,"zip":355,"country":345,"countryCode":346,"cosmosGeoPoint":356,"geoPoint":360,"contacts":55},"Centre Hospitalier Universitaire Vaudois (Chuv)","Lausanne","01011",{"type":92,"coordinates":357},[358,359],6.63282,46.516,{"lat":359,"lon":358},{"facility":362,"status":85,"city":363,"state":55,"zip":364,"country":345,"countryCode":346,"cosmosGeoPoint":365,"geoPoint":369,"contacts":55},"Kantonsspital St. Gallen","Sankt Gallen","09007",{"type":92,"coordinates":366},[367,368],9.37477,47.42391,{"lat":368,"lon":367},{"facility":371,"status":85,"city":372,"state":55,"zip":373,"country":374,"countryCode":375,"cosmosGeoPoint":376,"geoPoint":380,"contacts":55},"Cambridge University Hospitals Nhs Foundation Trust","Cambridge","CB2 0QQ","United Kingdom","UK",{"type":92,"coordinates":377},[378,379],0.11667,52.2,{"lat":379,"lon":378},{"facility":382,"status":85,"city":383,"state":55,"zip":384,"country":374,"countryCode":375,"cosmosGeoPoint":385,"geoPoint":389,"contacts":55},"Guys and St Thomas Nhs Foundation Trust","London","SE1 9RT",{"type":92,"coordinates":386},[387,388],-0.12574,51.50853,{"lat":388,"lon":387},{"facility":391,"status":85,"city":383,"state":55,"zip":392,"country":374,"countryCode":375,"cosmosGeoPoint":393,"geoPoint":395,"contacts":55},"Imperial College Healthcare Nhs Trust - Hammersmith Hospital","W12 0HS",{"type":92,"coordinates":394},[387,388],{"lat":388,"lon":387},{"facility":397,"status":85,"city":398,"state":55,"zip":399,"country":374,"countryCode":375,"cosmosGeoPoint":400,"geoPoint":404,"contacts":55},"The Christie Nhs Foundation Trust Uk","Manchester","M20 4BV",{"type":92,"coordinates":401},[402,403],-2.23743,53.48095,{"lat":403,"lon":402},{"facility":406,"status":85,"city":407,"state":55,"zip":408,"country":374,"countryCode":375,"cosmosGeoPoint":409,"geoPoint":413,"contacts":55},"Freeman Hospital Newcastle Upon Tyne Foundation Nhs Trust","Newcastle upon Tyne","NE7 7DN",{"type":92,"coordinates":410},[411,412],-1.61396,54.97328,{"lat":412,"lon":411},{"type":415,"investigatorFullName":55,"investigatorTitle":55,"investigatorAffiliation":55,"oldNameTitle":55,"oldOrganization":55},"SPONSOR","100503520","phase-1-a-study-to-evaluate-the-safety-of-inca33890-in-participants-with-advanced-or-metastatic-solid-tumors-100503520",false,"NCT05836324","A Study to Evaluate the Safety of INCA33890 in Participants With Advanced or Metastatic Solid Tumors","A Phase 1, Open-Label, Multicenter Study of INCA33890 in Participants With Advanced or Metastatic Solid Tumors","Inclusion Criteria:\n\n* ≥18 years old\n* Histologically or cytologically confirmed advanced or metastatic malignancies as defined in the protocol.\n* Part 1: Participants must have experienced disease progression after treatment with, be intolerant to, or be ineligible for, or refused available therapies, including anti-PD-(L)1 or anti-CTLA4 therapy if applicable, that are known to confer clinical benefit. Part 2: depending on cohort, participants may have received or not prior treatment for the malignancy under study.\n* ECOG performance status score of 0 or 1.\n* Willingness to undergo pre- and on-treatment tumor biopsy (core or excisional). Biopsies are mandatory depending on the cohorts.\n* Presence of measurable disease according to RECIST v1.1.\n\nExclusion Criteria:\n\n* Any known additional malignancy that is progressing or requires active treatment, or history of other malignancy within 2 years.\n* Not recovered to ≤ Grade 1 or baseline from residual toxicities of prior therapy.\n* Has active autoimmune disease requiring systemic immunosuppression with corticosteroids.\n* Brain or CNS metastases untreated or that have progressed.\n* History of organ transplant, including allogeneic stem cell transplantation.\n* History of clinically significant or uncontrolled cardiac disease.\n* Active HBV, active HCV, or HIV positive.\n* Is on chronic systemic steroids (\\> 10 mg\u002Fday of prednisone or equivalent).\n* Chronic or current active infectious disease requiring systemic antibiotics, antifungal, or antiviral treatment\n* Participants that have been initiated on or had modifications in anticoagulation therapies within the last 3 months prior to first dose of treatment.\n* Significant concurrent, uncontrolled medical condition, eg:\n\n  * Cardiovascular: Participants with known vasculitis, aneurisms, and other vascular malformations of clinical significance or history of myocarditis.\n  * Gastrointestinal: Any bowel obstruction within 60 days prior to C1D1.\n* Participants with adequate laboratory values within the protocol defined ranges.\n\nOther protocol-defined Inclusion\u002FExclusion Criteria may apply.","ALL","18 Years",{"count":426,"type":427},408,"ESTIMATED","INTERVENTIONAL",[430],"PHASE1","To evaluate the safety, tolerability, and DLTs and determine the MTD and\u002For RDE(s) of INCA33890 in participants with select advanced or metastatic solid tumors.",[433,434,435],"Solid Tumors","Advanced Solid Tumors","Metastatic Solid Tumors",[433,52],"2025-12-11",{"date":439,"type":440},"2025-12-18","ACTUAL",{"date":442,"type":440},"2023-07-24",{"date":444,"type":427},"2027-01-13",{"name":5,"class":6},36]